Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism; 2005 Aug;90(8):4888-94. PMID: 15886245
Category:
DPP-4s
Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.
Diabetes care; 2005 Aug;28(8):1936-40. PMID: 16043735Category:Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
Diabetes, Metabolic Syndrome and Obesity: Targets and TherapyCategory:
- Page 2 of 2
- Previous